Literature DB >> 8424727

Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging.

M C Brodsky1, C M Glasier.   

Abstract

Magnetic resonance imaging demonstrated coexistent central nervous system abnormalities in 30 of 40 patients with optic nerve hypoplasia. Based on their associated neuroradiological findings, these patients were placed into one of five categories: group 1, isolated optic nerve hypoplasia; group 2, absence of the septum pellucidum; group 3, posterior pituitary ectopia; group 4, hemispheric migration anomalies; and group 5, intrauterine/perinatal hemispheric injury. Posterior pituitary ectopia (group 3) and cerebral hemispheric abnormalities (groups 4 and 5) were found to be highly predictive of pituitary hormone deficiency and neurodevelopmental deficits, respectively. Isolated absence of the septum pellucidum (group 2) was associated with normal neurodevelopmental and endocrinologic function. Thinning or agenesis of the corpus callosum was predictive of neurodevelopmental problems only by virtue of its frequent association with cerebral hemispheric abnormalities. Magnetic resonance imaging can now be used to provide specific prognostic information regarding the likelihood of neurodevelopmental deficits and pituitary hormone deficiency in infants with optic nerve hypoplasia. The prevailing notion of septo-optic dysplasia as a distinct nosologic entity should be reconsidered.

Entities:  

Mesh:

Year:  1993        PMID: 8424727     DOI: 10.1001/archopht.1993.01090010070029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  26 in total

Review 1.  HESX1 and Septo-Optic Dysplasia.

Authors:  Mehul Tulsidas Dattani; Iain Caf Robinson
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

2.  Semiology of periventricular leucomalacia and its optic disc morphology.

Authors:  M C Brodsky
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

3.  VEP asymmetry with ophthalmological and MRI findings in two achiasmatic children.

Authors:  Jelka Brecelj; Branka Stirn-Kranjc; Nuska Pecaric-Meglic; Miha Skrbec
Journal:  Doc Ophthalmol       Date:  2007-01-13       Impact factor: 2.379

4.  A new imaging entity consistent with partial ectopic posterior pituitary gland: report of six cases.

Authors:  Marina Ybarra; Rawan Hafiz; Marie-Eve Robinson; Julia Elisabeth von Oettingen; Helen Bui; Christine Saint-Martin
Journal:  Pediatr Radiol       Date:  2019-08-30

5.  Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

6.  Brain Malformations Do Not Predict Hypopituitarism in Young Children with Optic Nerve Hypoplasia.

Authors:  Pamela Garcia-Filion; Hashem Almarzouki; Cassandra Fink; Mitchell Geffner; Marvin Nelson; Mark Borchert
Journal:  Horm Res Paediatr       Date:  2017-08-22       Impact factor: 2.852

7.  Infantile infection and diabetes insipidus in children with optic nerve hypoplasia.

Authors:  S P Donahue; A Lavina; J Najjar
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

8.  Brain visual impairment in childhood: mini review.

Authors:  N Kozeis
Journal:  Hippokratia       Date:  2010-10       Impact factor: 0.471

9.  Refining clinical phenotypes in septo-optic dysplasia based on MRI findings.

Authors:  Stefan Riedl; Jan Vosahlo; Tadej Battelino; Branka Stirn-Kranjc; Peter C Brugger; Daniela Prayer; Andrea Müllner-Eidenböck; Klaus Kapelari; Peter Blümel; Thomas Waldhör; Jan Krasny; Jan Lebl; Herwig Frisch
Journal:  Eur J Pediatr       Date:  2008-01-30       Impact factor: 3.183

10.  RetCam image analysis of optic disc morphology in premature infants and its relation to ischaemic brain injury.

Authors:  E McLoone; M O'Keefe; V Donoghue; S McLoone; N Horgan; B Lanigan
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.